β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli

The role of combination antibiotic therapy with a beta-lactam and a fluoroquinolone for bacteremia caused by gram-negative bacilli, to our knowledge, has not been previously described. Much of the previous study of combination therapy has included beta-lactams and aminoglycosides. We conducted a lar...

詳細記述

保存先:
書誌詳細
主要な著者: Al-Hasan, Majdi N., Wilson, John W., Lahr, Brian D., Thomsen, Kristine M., Eckel-Passow, Jeanette E., Vetter, Emily A., Tleyjeh, Imad M., Baddour, Larry M.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology (ASM) 2009
主題:
Clinical Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2663102/
https://ncbi.nlm.nih.gov/pubmed/19164144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01231-08
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料